Calreticulin-driven immunogenic cell death promotes osteoclast differentiation and osteoarthritis progression via the LRP1/Rac1 signaling
International Immunopharmacology · 2025-10 · 163 · 115277
DOI: 10.1016/j.intimp.2025.115277 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-10. Verfasst von Qi Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Third Ward of Orthopaedic Department, Institute of Osteoarthropathy, Institute of Medical Sciences, General Hospital of Ningxia Medical Universit…. Hauptthemen laut MEDLINE: Calreticulin, Osteoclasts, Osteoarthritis, Low Density Lipoprotein Receptor-Related Protein-1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ningxia Medical University.
Abstract (Originalsprache)
Aberrant osteoclast activation in subchondral bone is a hallmark of osteoarthritis (OA). This study identifies calreticulin (CALR), a key immunogenic cell death (ICD) marker, as a critical regulator of osteoclast differentiation and OA pathogenesis. Proteomic analysis revealed elevated CALR expression in subchondral bone from OA patients, which was further validated in human specimens and a destabilization of the medial meniscus (DMM)-induced murine OA model. In vitro, CALR upregulation during osteoclast differentiation activated the low-density lipoprotein receptor-related protein 1 (LRP1)/Ras-related C3 botulinum toxin substrate 1 (Rac1) signaling pathway, promoting osteoclastogenesis and bone resorption. These effects were suppressed by the apoptosis inhibitor zVAD-fmk or CALR knockdown. CALR-deficient mice exhibited attenuated subchondral bone damage and delayed OA progression post-DMM. Mechanistically, CALR governs osteoclast function via LRP1/Rac1-mediated nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) activation and secretion of bone-resorbing factors (matrix metalloproteinase-9 (MMP-9), cathepsin K (CTSK)). Our study establishes CALR as a novel therapeutic target for OA, bridging ICD to osteoclast-driven subchondral bone resorption and microarchitectural disruption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Third Ward of Orthopaedic Department, Institute of Osteoarthropathy, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, 750004, PR China; Ningxia…
- Ningxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, 750004, PR China.
- The Third Ward of Orthopaedic Department, Institute of Osteoarthropathy, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, 750004, PR China.
- The Third Ward of Orthopaedic Department, Institute of Osteoarthropathy, Institute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, 750004, PR China. Electron…
Förderung
- National Natural Science Foundation of China
- Ningxia Medical University
Zitieren
APA
Ma, Q., Lan, Z., Yang, Y., Sun, R., Xue, D., Lin, X., Su, Y., Ma, L., Hu, Z., Wu, G., He, X., Tian, K., & Jin, Q. (2025). Calreticulin-driven immunogenic cell death promotes osteoclast differentiation and osteoarthritis progression via the LRP1/Rac1 signaling. International Immunopharmacology, 163, 115277. https://doi.org/10.1016/j.intimp.2025.115277
Vancouver
Ma Q, Lan Z, Yang Y, Sun R, Xue D, Lin X, et al. Calreticulin-driven immunogenic cell death promotes osteoclast differentiation and osteoarthritis progression via the LRP1/Rac1 signaling. International Immunopharmacology. 2025;163:115277. doi:10.1016/j.intimp.2025.115277
BibTeX
@article{Ma2025,
author = {Ma, Qi and Lan, Zhibin and Yang, Yang and Sun, Rui and Xue, Di and Lin, Xue and Su, Yajing and Ma, Long and Hu, Zhijun and Wu, Gang and He, Xiaoxin and Tian, Kuanmin and Jin, Qunhua},
title = {Calreticulin-driven immunogenic cell death promotes osteoclast differentiation and osteoarthritis progression via the LRP1/Rac1 signaling},
journal = {International Immunopharmacology},
year = {2025},
volume = {163},
pages = {115277},
doi = {10.1016/j.intimp.2025.115277}
}
EUVIMED